 |
市場調查報告書
商品編碼
1477276
預防疫苗市場，依疫苗類型，依疾病類型，依配銷通路，依地理Preventive Vaccines Market, By Vaccine Type, By Disease Type, By Distribution Channel, By Geography |
||||||
預計2024年全球預防性疫苗市值為504.1億美元，預計2031年將達到963.5億美元，2024年至2031年年複合成長率（CAGR）為9.7%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年： | 2023年 | 2024 年市場規模： | 504.1 億美元 |
| 歷史數據： | 2019年至2023年 | 預測期： | 2024年至2031年 |
| 預測 2024 年至 2031 年複合年成長率： | 9.70% | 2031 年價值預測： | 963.5 億美元 |
由於世界各地各種傳染病負擔不斷增加，全球預防性疫苗市場正經歷一段成長期。預防性疫苗是增強對某些疾病的免疫力並有助於預防未來感染的生物製劑。多年來，疫苗學的各種進步促進了免疫接種的發展，以保護個人免受危及生命的疾病的侵害。此外，免疫意識的增強和疫苗技術的不斷創新也推動了對預防性疫苗的需求。一些國家政府實施了國家免疫規劃，以提高疫苗接種覆蓋率。公共和私人來源的傳染病醫療保健支出的增加也有助於預防性疫苗市場的擴大。然而，新疫苗開發的高昂研發成本以及低收入國家缺乏認知是阻礙市場成長的一些因素。
市場動態：
全球預防性疫苗市場的成長主要是由目標傳染病的盛行率不斷上升所推動的。新興國家與細菌和病毒感染相關的大量未滿足的醫療需求正在推動對免疫和疫苗接種計劃的需求。各國政府和非營利組織為加強國家免疫規劃所採取的各種措施增加了預防性疫苗的使用。例如，印度國家免疫計劃旨在免費提供針對 12 種危及生命的疾病的疫苗。疫苗產品開發的技術進步提高了免疫原性和穩定性，釋放了新的成長機會。然而，新疫苗研發、測試、臨床試驗和生產相關的高成本預計將在預測期內一定程度上抑制市場擴張。人們日益關注開發聯合疫苗以降低疫苗接種成本，這在未來幾年提供了利潤豐厚的機會。
研究的主要特點：
- 該報告對全球預防性疫苗市場進行了深入分析，並提供了以2023年為基準年的預測期（2024-2031年）的市場規模（十億美元）和年複合成長率（CAGR%）。
- 它闡明了不同區隔市場的潛在收入機會，並解釋了該市場有吸引力的投資主張矩陣。
- 這項研究還提供了有關市場促進因素、限制因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採取的競爭策略的重要見解。
- 它根據以下參數描述了全球預防性疫苗市場的主要參與者——公司亮點、產品組合、主要亮點、財務表現和策略。
- 該報告的見解將使行銷人員和公司管理當局能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
- 全球預防性疫苗市場迎合了該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進業者和金融分析師。
- 利害關係人可以透過用於分析全球預防性疫苗市場的各種策略矩陣輕鬆做出決策。
目錄
第1章：研究目標與假設
- 研究目標
- 假設
- 縮寫
第 2 章：市場範圍
- 報告說明
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map (COM)
第 3 章：市場動態、法規與趨勢分析
- 市場動態
- 促進要素
- 限制
- 機會
- 影響分析
- 市場走向
- 主要進展
- 監管場景
- 管道分析
- 流行病學
- 定價和品牌分析
- 製造商收入
- 收購和合作場景
- 產品發布/批准
- 資金和投資
- PEST分析
- 波特的分析
第 4 章：全球預防疫苗市場 - 冠狀病毒 (COVID-19) 大流行的影響
- 整體影響
- 政府舉措
- COVID-19 對市場的影響
第 5 章：全球預防疫苗市場，依疫苗類型，2019 - 2031 年（十億美元）
- 概述
- 活疫苗/減毒疫苗
- 去活化疫苗
- 亞單位疫苗
- 類毒素疫苗
- 其他
第 6 章：全球預防疫苗市場，依疾病類型，2019 - 2031 年（十億美元）
- 概述
- 肺炎球菌
- 小兒麻痺病毒
- 肝炎
- 流感
- 麻疹
- 風疹
- 其他
第 7 章：全球預防疫苗市場，依配銷通路分類，2019 - 2031 年（十億美元）
- 概述
- 民眾
- 私人的
第 8 章：全球預防疫苗市場，依地區分類，2019 - 2031 年（十億美元）
- 介紹
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
- 歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 歐洲其他地區
- 亞太地區
- 中國
- 印度
- 日本
- 東協
- 澳洲
- 韓國
- 亞太地區其他地區
- 中東
- 海灣合作理事會
- 以色列
- 中東其他地區
- 非洲
- 北非
- 中非
- 南非
第 9 章：競爭格局
- 公司簡介
- Sanofi
- Pfizer Inc.
- Merck & Co. Inc.
- GSK plc.
- Takeda Pharmaceutical Company Limited
- AstraZeneca
- Daiichi Sankyo Co. Ltd.
- Emergent BioSolutions Inc.
- Novavax Inc.
- Zydus Group
- Moderna, Inc.
- Sinopharm Group Co. Ltd.
- Valneva SE
- Serum Institute of India Pvt. Ltd.
- Johnson & Johnson Services, Inc.
- Bharat Biotech
- Regeneron Pharmaceuticals Inc.
第 10 章：分析師觀點
- 命運之輪
- 分析師觀點
- 連貫的機會圖
第 11 章：參考文獻與研究方法
- 參考
- 研究方法論
The global preventive vaccines market is estimated to be valued at USD 50.41 Bn in 2024 and is expected to reach USD 96.35 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 9.7% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 50.41 Bn |
| Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 To 2031 |
| Forecast Period 2024 to 2031 CAGR: | 9.70% | 2031 Value Projection: | US$ 96.35 Bn |
The global preventive vaccines market is witnessing a period of growth owing to the rising burden of various infectious diseases across the world. Preventive vaccines are biological preparations that enhance immunity against certain diseases and help prevent future infections. Over the years, various advancements in vaccinology have enabled the development of immunization to safeguard individuals from life-threatening illnesses. Moreover, growing awareness regarding immunization and continuous innovation in vaccine technologies are fueling the demand for preventive vaccines. Governments of several countries have implemented national immunization programs to promote vaccination coverage. Rising healthcare expenditures on communicable diseases from public and private sources are also contributing to the expansion of the preventive vaccines market. However, high research and development costs involved in new vaccine development and lack of awareness in low-income nations are some of the factors hindering the market growth.
Market Dynamics:
The global preventive vaccines market growth is primarily driven by the increasing prevalence of target infectious diseases. Significant unmet medical needs associated with bacterial and viral infections across the emerging nations are driving the demand for immunization and vaccination programs. Various initiatives taken by governments and non-profit organizations to strengthen national immunization programs have augmented the uptake of preventive vaccines. For instance, the National Immunization Program of India aims to provide vaccines against 12 life-threatening diseases free of cost. Technological advancements in vaccine product development with improved immunogenicity and stability have unlocked new growth opportunities. However, high costs associated with new vaccine R&D, testing, clinical trials, and production are expected to restrain the market expansion to some extent during the forecast period. Rising focus on development of combination vaccines to lower vaccination costs offers lucrative opportunities in the forthcoming years.
Key Features of the Study:
- This report provides in-depth analysis of the global preventive vaccines market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global preventive vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study Sanofi, Pfizer Inc., Merck & Co. Inc., GSK plc., Takeda Pharmaceutical Company Limited, AstraZeneca, Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., Novavax Inc., Zydus Group, Moderna, Inc., Sinopharm Group Co. Ltd., Valneva SE, Serum Institute of India Pvt. Ltd., Johnson & Johnson Services, Inc., Bharat Biotech, and Regeneron Pharmaceuticals Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global preventive vaccines market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global preventive vaccines market.
Detailed Segmentation-
- By Vaccine Type:
- Live/Attenuated Vaccines
- Inactivated Vaccines
- Subunit Vaccines
- Toxoid Vaccines
- Others
- By Disease Type:
- Pneumococcal
- Poliovirus
- Hepatitis
- Influenza
- Measles
- Rubella
- Others
- By Distribution Channel:
- Public
- Private
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Sanofi
- Pfizer Inc.
- Merck & Co. Inc.
- GSK plc.
- Takeda Pharmaceutical Company Limited
- AstraZeneca
- Daiichi Sankyo Co. Ltd.
- Emergent BioSolutions Inc.
- Novavax Inc.
- Zydus Group
- Moderna, Inc.
- Sinopharm Group Co. Ltd.
- Valneva SE
- Serum Institute of India Pvt. Ltd.
- Johnson & Johnson Services, Inc.
- Bharat Biotech
- Regeneron Pharmaceuticals Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Vaccine Type
- Market Snapshot, By Disease Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Pipeline Analysis
- Epidemiology
- Pricing and Brand Analysis
- Manufacturer Revenue
- Acquisitions and Partnerships Scenario
- Product Launches/Approvals
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Preventive Vaccines Market- Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the market
5. Global Preventive Vaccines Market, By Vaccine Type, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Live/Attenuated Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Inactivated Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Subunit Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Toxoid Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Preventive Vaccines Market, By Disease Type, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Pneumococcal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Poliovirus
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Hepatitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Influenza
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Measles
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Rubella
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Preventive Vaccines Market, By Distribution Channel, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Public
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Private
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Preventive Vaccines Market, By Region, 2019 - 2031, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Regions, 2019-2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pfizer Inc.
- Merck & Co. Inc.
- GSK plc.
- Takeda Pharmaceutical Company Limited
- AstraZeneca
- Daiichi Sankyo Co. Ltd.
- Emergent BioSolutions Inc.
- Novavax Inc.
- Zydus Group
- Moderna, Inc.
- Sinopharm Group Co. Ltd.
- Valneva SE
- Serum Institute of India Pvt. Ltd.
- Johnson & Johnson Services, Inc.
- Bharat Biotech
- Regeneron Pharmaceuticals Inc.
10. Analyst View
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
![狂犬病疫苗市場 - 按產品類型 [嬰兒倉鼠腎 (BHK)、Vero 細胞狂犬病疫苗]、類型（人用、獸用）、應用（暴露前預防、暴露後預防）、配銷通路、全球預測（2024 年- 2032 年）](/sample/img/cover/42/1535700.png)
狂犬病疫苗市場 - 按產品類型 [嬰兒倉鼠腎 (BHK)、Vero 細胞狂犬病疫苗]、類型（人用、獸用）、應用（暴露前預防、暴露後預防）、配銷通路、全球預測（2024 年- 2032 年）
狂犬病疫苗市場，按產品類型、應用、預防類型、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測
人類狂犬病疫苗市場：細胞株類型、給藥途徑、應用、配銷通路- 全球預測 2024-2030
狂犬病疫苗市場：按產品類型、按預防類型、按應用、按最終用戶：2023-2032 年全球機會分析和產業預測
狂犬病疫苗市場報告：2030 年趨勢、預測與競爭分析
百日咳疫苗市場報告：2030 年趨勢、預測與競爭分析
滅活脊髓灰質炎·狂犬病(恐水症)疫苗市場:疫苗，各滅活方法，各年齡層，各流通管道，各地區- 市場規模，佔有率，展望，機會分析，2023年～2030年
2023-2030 年全球預防性疫苗市場